Author:
Bommi Sivaganesh,Jayanty Subbalakshmi,Tirumalaraju Satyanarayana Raju,Kola Suresh,Kallam Venkata Siva Rama Krishna Reddy
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry
Reference31 articles.
1. Liu K, Chen C (2019) Determination of impurities in pharmaceuticals: Why and How? Quality management and quality control-new trends and developments. IntechOpen, London, pp 1–17
2. EMEA (2006) Q 3 A (R2) Impurities in new drug substances note for guidance on impurities testing: impurities in new drug substances. EMEA Eur Med Agency
3. Prajapati P, Agrawal YK (2014) Analysis and impurity identification in pharmaceuticals. Rev Anal Chem 33:123–133. https://doi.org/10.1515/revac-2014-0001
4. Nair AKMU (2015) Impact of API (Active Pharmaceutical Ingredient) source selection on generic drug products. Pharm Regul Aff Open Access. https://doi.org/10.4172/2167-7689.1000136
5. Chen C, Wu D, Guo Z, et al (2008) (Elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin- releasing hormone receptor. Receptor, pp 7478–7485
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献